openPR Logo
Press release

Todd Wallach and Paul Sohmer, MD join Oran Diagnostics’ Board of Managers

12-22-2010 09:57 AM CET | Health & Medicine

Press release from: LearnWell

BERWYN, PA, October 1, 2010—Oran Diagnostics, LLC, a specialized medical device company developing novel clinical diagnostic tools for applications across a broad spectrum of disease states, today announced that Todd Wallach and Paul Sohmer, MD have joined the Company’s Board of Managers.

Mr. Wallach is the Chairman and Chief Executive Officer of Molecular Detection, Inc. (MDI). MDI is developing and commercializing a portfolio of "sample-to-answer" Detect-Ready™ molecular diagnostic tests for the rapid detection of infectious diseases. With more than 20 years of experience in operations, finance and strategy, Mr. Wallach is a successful life sciences entrepreneur who has helped found companies with a combined market capitalization of over $500 million. Prior to MDI, Mr. Wallach was chief financial officer and a member of the founding management team of specialty pharmaceutical company Aton Pharma, Inc., which was acquired by Valeant. He was previously vice president of finance and operations and a member of the founding management team of Acuity Pharmaceuticals, Inc., which was acquired by publicly traded OPKO Health. Earlier in his career, Mr. Wallach was a management consultant at Booz Allen Hamilton. Mr. Wallach received an M.S. in technology management from the Wharton School of Business and the School of Engineering and Applied Science at the University of Pennsylvania, an M.S. in biotechnology from the University of Pennsylvania, an M.B.A. from Rider University, and a B.S. in mechanical engineering from Purdue University.

Dr. Sohmer has served as CEO of both public and privately held growth companies focused on medical devices, biotechnology, and health care services. He is currently Chief Executive Officer of Orthocon, Inc., which develops, manufactures, markets, and sells implantable products designed to stop the bleeding from and to deliver drugs to bone. Prior to Orthocon he served as Chairman, President and CEO of TriPath Imaging, Inc., which was sold to Becton Dickinson and Associates (BD) in December of 2006. Previously he served as President and CEO of Neuromedical Systems, Inc., Genetrix, Inc., and the Pathology Institute, Inc. Dr. Sohmer was named North Carolina Life Sciences Entrepreneur of the Year in 2005.

“The addition of Mr. Wallach and Dr. Sohmer to Oran’s Board of Managers brings an enormous wealth of resources to the Company as it moves down the path of commercialization of its novel diagnostic and prognostic technologies,” said Bruce Goldstein, Founder and Chief Executive Officer of Oran. "Mr. Wallach and Dr. Sohmer are entrepreneurial leaders with proven track records of success, and their individual and collective experience in building successful research and development and commercial infrastructures will be invaluable to Oran."

About Oran Diagnostics

Oran Diagnostics, LLC is using its proprietary device (the TCL Analyzer™) and method (thermochemiluminescence) to develop accurate, minimally invasive clinical tools for use in clinical diagnostics, and for drug discovery and development. The company’s proprietary technology is currently being applied in cardiovascular and neurodegenerative disease. Oran Diagnostics is headquartered in Berwyn, PA, with research and development facilities in Haifa, Israel. For more information, please visit www.orandx.com.

TCL-HF™ is a rapid, minimally invasive procedure for designed to aid in the risk stratification of patients diagnosed with heart failure. The TCL Analyzer™ measures lipid peroxidation in a small sample (50 microlitres) of blood serum. Using a highly sensitive, proprietary method of biomarker identification (thermochemiluminescence), TCL-HF™ measures the level of oxidative stress and oxidizability, which measurement correlates with the degree of disease severity. Analysis can be performed in a hospital or clinical laboratory in just minutes. TCL-HF™ provides a relevant, previously unavailable clinical data point that helps guide treatment options for patients with heart failure. The TCL Analyzer™ and TCL-HF™ are not currently cleared for use in the U.S. by the Food and Drug Administration.

Contact: Meredith Hegg
491 Baltimore Pike Suite 209
Springfield, PA 19064
Phone: 610-626-0175

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Todd Wallach and Paul Sohmer, MD join Oran Diagnostics’ Board of Managers here

News-ID: 156087 • Views: 954

More Releases from LearnWell

Bill Ringle Interviews Business Sales Expert Mark Satterfield on My Quest for Be …
Bill Ringle, America’s Business Growth Strategist, talked with Mark Satterfield, CEO of Gentle Rain Marketing, for the interview show My Quest for the Best. Philadelphia, PA, May 06, 2012 - Business growth strategist Bill Ringle interviewed Mark Satterfield, CEO of Gentle Rain Marketing and author of Unique Sales Stories, for My Quest for the Best. In this interview series, Ringle speaks with successful industry experts and outstanding business leaders about their
Oran Diagnostics Adds Reproductive Health to License Agreement with Carmel Diagn …
BERWYN, PA, February 14, 2011. Oran Diagnostics, LLC, a privately held diagnostics company, today announced that it has expanded its exclusive worldwide license agreement with Carmel Diagnostics, Ltd. of Kiryat Tivon, Israel, to include reproductive health. This expansion into reproductive medicine enables Oran to continue development of TCL-EV™, a rapid, non-invasive procedure that can be used to identify embryos with the greatest reproductive potential in patients undergoing IVF. TCL-EV™ is
Greater Philadelphia Business Owners Gather to Find Out How to “Become Famous …
Philadelphia, PA - January 14, 2011 - On January 11, 2011, Bill Ringle, founder of Rainmaker Academy, partnered with the Baiada Center at Drexel University to lead a half-day session titled “Become Famous In Your Niche so Business Comes to You”. Ringle led a full room of entrepreneurs and business owners through tips, insights and practical lessons in business development and marketing. While navigating topics such as defining your
Oran Diagnostics Announces Appointments to Scientific Advisory Board
BERWYN, PA, October 12, 2010—Oran Diagnostics, LLC, a specialized medical device company developing novel clinical diagnostic tools for applications across a broad spectrum of disease states, today announced that it has finalized the composition of its scientific advisory board with the addition of two new members. Comprised of world-renowned cardiologists and scientists, the advisory board will play an important role in guiding and participating in Oran’s research and clinical development

All 5 Releases


More Releases for Wallach

Electronic Colposcope Market 2020 to 2026 | Top Companies Leisegang, Wallach, We …
Up Market Research (UMR), one of the world's prominent market research firms has announced a novel report on Global Electronic Colposcope Market. The report contains vital insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Electronic Colposcope market to figure out and study the market needs, market size, and competition. The report incorporates data
Medical Gynecological Devices Market Key Players: Wallach & Company, Boston Scie …
The report on the Global Medical Gynecological Devices Market provides a complete view of the market by assessing the impact of the technological advancements, changes in investment habits, and in-depth overview of Product Specification. This Medical Gynecological Devices report is a valuable source of guidance for companies and individuals offering Industry Chain Structure, Business Strategies and Proposals for New Project Investments also analyzes the Medical Gynecological Devices industry status, market share,
Trends: Fetal Activity Monitor Market By Key Vendors: Edan, Huntleigh, GE, Natus …
Qyresearchreports include new market research report Fetal Activity Monitor to its huge collection of research reports. This report studies the global Fetal Activity Monitor market status and forecast, categorizes the global Fetal Activity Monitor market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Fetal activity monitors are diagnostic devices utilized
Global Cryosurgery Devices Market 2017-2021 | Brymill Cryogenic Systems, Medtron …
Cryosurgery is a non-invasive therapy used to alleviate pain, treat abnormal skin conditions, and destroy localized tumors. Cryosurgery can be administered locally or on the whole body. The surgeon uses cryoprobes to deliver liquid nitrogen or high-pressure argon gas to freeze and destroy tumor cells. Magnetic resonance imaging (MRI), ultrasound, or computed tomography (CT) scan is used to guide the cryoprobe to the treatment site. The global cryosurgery devices market
Global Disposable Dialysis Equipment Sales Market Report 2017 - B.Braun, Thermo …
Albany, New York, August 21, 2017 : Recent research and the current scenario as well as future market potential of " Research of Disposable Dialysis Equipment Sales Market in Global Industry : Development and Forecast 2017-2022 " globally. In this report, the Disposable Dialysis Equipment market is valued and is expected to grow day by day at the end of 2022 . Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1268198 Geographically,
Colposcope Market 2017 Top Companies - Wallach, Welch Allyn, Seiler, Zeiss, ATMO …
Global Colposcope Industry Report offers market size, share, overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. This Colposcope market report values the industry in USD million terms for 2016, expected USD million value by the end of 2022 is provided, showing a steady CAGR percentage number between 2016